Dexamethasone uptake in the murine organ of Corti with transtympanic versus systemic administration
- PMID: 23663237
- PMCID: PMC3651220
- DOI: 10.1186/1916-0216-42-19
Dexamethasone uptake in the murine organ of Corti with transtympanic versus systemic administration
Abstract
Objective: To investigate glucocorticoid uptake in auditory hair cells following transtympanic versus systemic administration of dexamethasone.
Study design: Controlled experimental study.
Setting: Translational science experimental laboratory.
Methods: Swiss-Webster mice were injected with dexamethasone via transtympanic or systemic administration. At 1, 6, or 12 hours post-injection the temporal bones were harvested. After cryosectioning, immunohistochemical staining was performed using an antibody for dexamethasone.
Results: Dexamethasone labelling was greatest at 1 hour. Inner hair cells demonstrated much higher steroid uptake than outer hair cells. Both transtympanic injection and high-dose systemic administration resulted in strong dexamethasone labelling of hair cells, and a decreasing basal-to-apical gradient of hair cell fluorescence intensity was observed. Systemically delivered dexamethasone was rapidly eliminated from the inner ear, demonstrating mild labelling after 6 hours and none after 12 hours. In contrast, the mice receiving transtympanic injection had persistent moderate intensity fluorescence at 6 and 12 hours post-injection.
Conclusion: There is similar uptake of dexamethasone by auditory hair cells after transtympanic and high-dose systemic delivery. Novel findings include the presence of a decreasing basal-apical gradient of steroid uptake, and demonstration of greater affinity of inner hair cells for dexamethasone compared to outer hair cells. In this animal model transtympanic injection resulted in prolonged steroid uptake. These findings help further our understanding of the pharmacokinetics of steroids in the cochlea, with a focus on auditory hair cells.
Figures



Similar articles
-
Steroid intracochlear distribution differs by administration method: Systemic versus intratympanic injection.Laryngoscope. 2018 Jan;128(1):189-194. doi: 10.1002/lary.26562. Epub 2017 Mar 17. Laryngoscope. 2018. PMID: 28304075
-
Effect of transtympanic betamethasone delivery to the inner ear.Eur Arch Otorhinolaryngol. 2016 Oct;273(10):3053-61. doi: 10.1007/s00405-016-3905-9. Epub 2016 Jan 29. Eur Arch Otorhinolaryngol. 2016. PMID: 26831119
-
Intratympanic injection of dexamethasone: time course of inner ear distribution and conversion to its active form.Otol Neurotol. 2006 Jun;27(4):564-9. doi: 10.1097/01.mao.0000194814.07674.4f. Otol Neurotol. 2006. PMID: 16691147
-
Transtympanic perfusion: indications and limitations.Curr Opin Otolaryngol Head Neck Surg. 2004 Oct;12(5):378-83. doi: 10.1097/01.moo.0000134438.91734.38. Curr Opin Otolaryngol Head Neck Surg. 2004. PMID: 15377947 Review.
-
Mechanisms of hearing loss from trauma and inflammation: otoprotective therapies from the laboratory to the clinic.Acta Otolaryngol. 2010 Mar;130(3):308-11. doi: 10.1080/00016480903124655. Acta Otolaryngol. 2010. PMID: 19579145 Review.
Cited by
-
Drug Diffusion Along an Intact Mammalian Cochlea.Front Cell Neurosci. 2019 Apr 26;13:161. doi: 10.3389/fncel.2019.00161. eCollection 2019. Front Cell Neurosci. 2019. PMID: 31080407 Free PMC article.
-
Local Drug Delivery to the Entire Cochlea without Breaching Its Boundaries.iScience. 2020 Mar 27;23(3):100945. doi: 10.1016/j.isci.2020.100945. Epub 2020 Feb 26. iScience. 2020. PMID: 32151971 Free PMC article.
-
A Comparative Study of Drug Delivery Methods Targeted to the Mouse Inner Ear: Bullostomy Versus Transtympanic Injection.J Vis Exp. 2017 Mar 8;(121):54951. doi: 10.3791/54951. J Vis Exp. 2017. PMID: 28362376 Free PMC article.
-
Advances and Challenges in Pharmaceutical Therapies to Prevent and Repair Cochlear Injuries From Noise.Front Cell Neurosci. 2019 Jun 26;13:285. doi: 10.3389/fncel.2019.00285. eCollection 2019. Front Cell Neurosci. 2019. PMID: 31297051 Free PMC article. Review.
-
Intracochlear administration of steroids with a catheter during human cochlear implantation: a safety and feasibility study.Drug Deliv Transl Res. 2018 Oct;8(5):1191-1199. doi: 10.1007/s13346-018-0539-z. Drug Deliv Transl Res. 2018. PMID: 29761349
References
-
- Chen Y, Wen L, Hu P, Qiu J, Lu L, Qiao L. Endoscopic intratympanic methylprednisolone injection for treatment of refractory sudden sensorineural hearing loss and one case in pregnancy. J Otolaryngol Head Neck Surg. 2010;39(6):640–645. - PubMed
-
- Lee HS, Kim JM, Kim YJ, Chung DH, Seo BS, Kim SH. Results of intratympanic dexamethasone injection as salvage treatment in idiopathic sudden hearing loss. J Otolaryngol Head Neck Surg. 2008;37(2):263–268. - PubMed
-
- Plontke SK, Löwenheim H, Mertens J. Randomized, double blind, placebo controlled trial on the safety and efficacy of continuous intratympanic dexamethasone delivered via a round window catheter for severe to profound sudden idiopathic sensorineural hearing loss after failure of systemic therapy. Laryngoscope. 2009;119:359–369. doi: 10.1002/lary.20074. - DOI - PubMed
-
- Silverstein H, Issacson JE, Olds MJ. Dexamethasone inner ear perfusion for the treatment of Meniere’s disease: A prospective, randomized, double-blind, crossover trial. Am J Otol. 1998;19:196–201. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical